These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32600910)

  • 1. Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers.
    Kartoglu UH; Moore KL; Lloyd JS
    Vaccine; 2020 Jul; 38(34):5393-5395. PubMed ID: 32600910
    [No Abstract]   [Full Text] [Related]  

  • 2. Emerging manufacturers engagements in the COVID -19 vaccine research, development and supply.
    Pagliusi S; Jarrett S; Hayman B; Kreysa U; Prasad SD; Reers M; Hong Thai P; Wu K; Zhang YT; Baek YO; Kumar A; Evtushenko A; Jadhav S; Meng W; Dat DT; Huang W; Desai S
    Vaccine; 2020 Jul; 38(34):5418-5423. PubMed ID: 32600908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 vaccines for all?
    Usher AD
    Lancet; 2020 Jun; 395(10240):1822-1823. PubMed ID: 32534638
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID vaccination logistics: five steps to take now.
    Teerawattananon Y; Dabak SV
    Nature; 2020 Nov; 587(7833):194-196. PubMed ID: 33168970
    [No Abstract]   [Full Text] [Related]  

  • 5. Global governance for COVID-19 vaccines.
    The Lancet
    Lancet; 2020 Jun; 395(10241):1883. PubMed ID: 32563355
    [No Abstract]   [Full Text] [Related]  

  • 6. If a coronavirus vaccine arrives, can the world make enough?
    Khamsi R
    Nature; 2020 Apr; 580(7805):578-580. PubMed ID: 32273621
    [No Abstract]   [Full Text] [Related]  

  • 7. Coronavirus: global solutions to prevent a pandemic.
    Watts CH; Vallance P; Whitty CJM
    Nature; 2020 Feb; 578(7795):363. PubMed ID: 32071448
    [No Abstract]   [Full Text] [Related]  

  • 8. Intensifying vaccine production.
    Bull World Health Organ; 2020 May; 98(5):302-303. PubMed ID: 32514194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why do SARS-COV vaccines not exist? The pharma scientific intelligence and business model must be revisited!
    Boudjelal M; Nehdi A; Islam I
    Expert Opin Drug Discov; 2020 Nov; 15(11):1233-1235. PubMed ID: 32543297
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 vaccines: how to ensure Africa has access.
    Nkengasong JN; Ndembi N; Tshangela A; Raji T
    Nature; 2020 Oct; 586(7828):197-199. PubMed ID: 33024330
    [No Abstract]   [Full Text] [Related]  

  • 11. Covid-19 and the race for a vaccine.
    Cueto M
    Hist Cienc Saude Manguinhos; 2020; 27(3):715-717. PubMed ID: 33111785
    [No Abstract]   [Full Text] [Related]  

  • 12. What China's speedy COVID vaccine deployment means for the pandemic.
    Cyranoski D
    Nature; 2020 Oct; 586(7829):343-344. PubMed ID: 33033397
    [No Abstract]   [Full Text] [Related]  

  • 13. Plan now to speed vaccine supply for future pandemics.
    Bingham K
    Nature; 2020 Oct; 586(7828):171. PubMed ID: 33024331
    [No Abstract]   [Full Text] [Related]  

  • 14. What a Joe Biden presidency would mean for five key science issues.
    Maxmen A; Subbaraman N; Tollefson J; Viglione G; Witze A
    Nature; 2020 Oct; 586(7828):177-180. PubMed ID: 33005052
    [No Abstract]   [Full Text] [Related]  

  • 15. Audio Interview: Guidelines for Covid-19 Vaccine Deployment.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Sep; 383(11):e88. PubMed ID: 32905696
    [No Abstract]   [Full Text] [Related]  

  • 16. Keeping track of the SARS-CoV-2 vaccine pipeline.
    Parker EPK; Shrotri M; Kampmann B
    Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Jun; 16(696):1176-1177. PubMed ID: 32496711
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress and Concept for COVID-19 Vaccine Development.
    Wu SC
    Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
    [No Abstract]   [Full Text] [Related]  

  • 19. Global collaboration for health: rhetoric versus reality.
    The Lancet
    Lancet; 2020 Sep; 396(10253):735. PubMed ID: 32919496
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial.
    Usmani SS; Raghava GPS
    Front Immunol; 2020; 11():561851. PubMed ID: 33133071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.